Real-time enrollment status for this biliary tract cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT03482102 |
| Recruiting Status | Recruiting |
| Condition | Biliary Tract Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 70 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | September 8, 2022 (Sep 8, 2022) |
As of March 2, 2026: Clinical trial NCT03482102 is currently recruiting participants. This clinical trial study for biliary tract cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03482102 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03482102 was last updated Sep 8, 2022 (September 8, 2022). HelloStudys verifies this status automatically.